Authors: CHRISTODOULOPOULOS G FOTOUHI N KRAJEWSKI S REED JC ALAOUIJAMALI M PANASCI L

Citation: G. Christodoulopoulos et al., RELATIONSHIP BETWEEN NITROGEN-MUSTARD DRUG-RESISTANCE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND PROTEIN EXPRESSION OF BCL-2, BAX, BCL-X AND P53, Cancer letters, 121(1), 1997, pp. 59-67

Authors: ALAOUIJAMALI M MITRA S

Citation: M. Alaouijamali et S. Mitra, DNA-REPAIR AND ITS REGULATORY PATHWAYS IN CANCER PHARMACOLOGY, MS. Medecine sciences, 12(6-7), 1996, pp. 766-773

Authors: WANG TQ CHEN X SCHECTER RL BARUCHEL S ALAOUIJAMALI M MELNYCHUK D BATIST G

Citation: Tq. Wang et al., MODULATION OF GLUTATHIONE BY A CYSTEINE PRO-DRUG ENHANCES IN-VIVO TUMOR RESPONSE, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1169-1173

Authors: BRAMSON J MCQUILLAN A AUBIN R ALAOUIJAMALI M BATIST G CHRISTODOULOPOULOS G PANASCI LC

Citation: J. Bramson et al., NITROGEN-MUSTARD DRUG-RESISTANT B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA AS AN IN-VIVO MODEL FOR CROSS-LINKING AGENT RESISTANCE, Mutation research. DNA repair, 336(3), 1995, pp. 269-278

Authors: ALAOUIJAMALI M LOUBABA BB ROBYN S TAPIERO H BATIST G

Citation: M. Alaouijamali et al., EFFECT OF DNA-REPAIR-ENZYME MODULATORS ON CYTOTOXICITY OF L-PHENYLALANINE MUSTARD AND CIS-DIAMMINEDICHLOROPLATINUM(II) IN MAMMARY-CARCINOMACELLS RESISTANT TO ALKYLATING DRUGS, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 153-158

Authors: BRAMSON J PREVOST J MALAPETSA A NOE AJ POIRIER GG DESNOYERS S ALAOUIJAMALI M PANASCI L

Citation: J. Bramson et al., POLY(ADP-RIBOSE) POLYMERASE CAN BIND MELPHALAN DAMAGED DNA, Cancer research, 53(22), 1993, pp. 5370-5373